+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Cardiac Restoration Systems Market 2019-2023 - Product Image

Global Cardiac Restoration Systems Market 2019-2023

  • ID: 4772986
  • Report
  • May 2019
  • Region: Global
  • 125 pages
  • TechNavio
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Abbott
  • BioVentrix Inc.
  • CryoLife Inc.
  • NeoChord Inc.
  • Xeltis AG
  • MORE
CVDs are a class of diseases that affect the heart and blood vessels with conditions such as coronary heart disease, stroke, peripheral arterial disease, and aortic disease. They are usually caused due to the high risk of blood clots and fatty deposition in arteries. Blockage of the blood flow into the heart valve leads to regurgitation and stenosis. The increasing number of mitral valve regurgitation, mitral valve stenosis, and heart failure cases, where the heart cannot pump enough blood and oxygen to other parts of the body, is driving the market growth. Hence, the demand for cardiovascular restoration devices is expected to increase to treat the damaged and diseased heart valves, which, in turn, drives the market growth. Analysts have predicted that the cardiac restoration systems market will register a CAGR of over 5% by 2023.

Market Overview

Growing medical tourism in emerging economies

Medical tourism refers to patients traveling to countries such as Singapore, Malaysia, Thailand, and India to obtain medical treatment with high-quality healthcare, affordability, and accessibility benefits. Medical tourism is a booming industry, as each medical expertise is focused on offering niche services to attract foreign patients. The rise in quality of medical services and infrastructure in developing economies is a contributor to the growth of medical tourism, which propels the growth of the global cardiac restoration systems market during the forecast period.

Increasing number of product recalls

A product recall is a process of retrieving defective cardiac restoration systems from consumers with compensation. Product recalls tending to occur when there is a manufacturing defect in the product, which causes potential health-related risks to consumers. The increasing number of products recalls by manufacturers can slow down the launch of products in the market, affecting the sales and revenues of vendors, which, in turn, hinders the global cardiac restoration systems market growth.

Competitive Landscape

The market appears to be fairly concentrated. The presence of few companies including Abbott and BioVentrix Inc., the competitive environment is quite intense. Vendors in the global cardiac restoration systems market are focused on implementing developmental strategies such as M&A and high R&D investments to improve their market share and expand their presence globally. CryoLife Inc., Edwards Lifesciences Corp., NeoChord Inc., and Xeltis AG are some of the major companies covered in this report.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott
  • BioVentrix Inc.
  • CryoLife Inc.
  • NeoChord Inc.
  • Xeltis AG
  • MORE

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

  • Preface
  • Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 04: MARKET SIZING

  • Market definition
  • Market sizing 2018
  • Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

  • Market segmentation by product
  • Comparison by product
  • Mitral valve restoration systems - Market size and forecast 2018-2023
  • Left ventricular restoration systems - Market size and forecast 2018-2023
  • Market opportunity by product

PART 07: MARKET SEGMENTATION BY END-USER

  • Market segmentation by end-user
  • Comparison by end-user
  • Hospitals - Market size and forecast 2018-2023
  • ASCs - Market size and forecast 2018-2023
  • Others - Market size and forecast 2018-2023
  • Market opportunity by end-user

PART 08: CUSTOMER LANDSCAPE

PART 09: GEOGRAPHIC LANDSCAPE

  • Geographic segmentation
  • Geographic comparison
  • North America - Market size and forecast 2018-2023
  • Europe - Market size and forecast 2018-2023
  • Asia - Market size and forecast 2018-2023
  • ROW - Market size and forecast 2018-2023
  • Key leading countries
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Development of mitral valve restoration systems with tissue engineering approach
  • High R&D investments and M&A activities
  • Growing awareness about cardiac restoration systems

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Abbott
  • BioVentrix Inc.
  • CryoLife Inc.
  • Edwards Lifesciences Corp.
  • NeoChord Inc.
  • Xeltis AG

PART 15: APPENDIX

  • Research methodology
  • List of abbreviations
  • Definition of market positioning of vendors

PART 16: EXPLORE

List of Exhibits:
Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market characteristics analysis
Exhibit 05: Market segments
Exhibit 06: Market definition - Inclusions and exclusions checklist
Exhibit 07: Market size 2018
Exhibit 08: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 09: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 10: Five forces analysis 2018
Exhibit 11: Five forces analysis 2023
Exhibit 12: Bargaining power of buyers
Exhibit 13: Bargaining power of suppliers
Exhibit 14: Threat of new entrants
Exhibit 15: Threat of substitutes
Exhibit 16: Threat of rivalry
Exhibit 17: Market condition - Five forces 2018
Exhibit 18: Product - Market share 2018-2023 (%)
Exhibit 19: Comparison by product
Exhibit 20: Mitral valve restoration systems - Market size and forecast 2018-2023 ($ millions)
Exhibit 21: Mitral valve restoration systems - Year-over-year growth 2019-2023 (%)
Exhibit 22: Left ventricular restoration systems - Market size and forecast 2018-2023 ($ millions)
Exhibit 23: Left ventricular restoration systems - Year-over-year growth 2019-2023 (%)
Exhibit 24: Market opportunity by product
Exhibit 25: End-user - Market share 2018-2023 (%)
Exhibit 26: Comparison by end-user
Exhibit 27: Hospitals - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: Hospitals - Year-over-year growth 2019-2023 (%)
Exhibit 29: ASCs - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: ASCs - Year-over-year growth 2019-2023 (%)
Exhibit 31: Others - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Others - Year-over-year growth 2019-2023 (%)
Exhibit 33: Market opportunity by end-user
Exhibit 34: Customer landscape
Exhibit 35: Customer landscape analysis
Exhibit 36: Market share by geography 2018-2023 (%)
Exhibit 37: Geographic comparison
Exhibit 38: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 39: North America - Year-over-year growth 2019-2023 (%)
Exhibit 40: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 41: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 42: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 43: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 44: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 45: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 46: Key leading countries
Exhibit 47: Market opportunity
Exhibit 48: Impact of drivers and challenges
Exhibit 49: Vendor landscape
Exhibit 50: Landscape disruption
Exhibit 51: Vendor landscape analysis
Exhibit 52: Vendors covered
Exhibit 53: Vendor classification
Exhibit 54: Market positioning of vendors
Exhibit 55: Abbott - Vendor overview
Exhibit 56: Abbott - Business segments
Exhibit 57: Abbott - Organizational developments
Exhibit 58: Abbott - Geographic focus
Exhibit 59: Abbott - Segment focus
Exhibit 60: Abbott - Key offerings
Exhibit 61: BioVentrix Inc. - Vendor overview
Exhibit 62: BioVentrix Inc. - Business segments
Exhibit 63: BioVentrix Inc. - Key offerings
Exhibit 64: CryoLife Inc. - Vendor overview
Exhibit 65: CryoLife Inc. - Product segments
Exhibit 66: CryoLife Inc. - Organizational developments
Exhibit 67: CryoLife Inc. - Geographic focus
Exhibit 68: CryoLife Inc. - Segment focus
Exhibit 69: CryoLife Inc. - Key offerings
Exhibit 70: Edwards Lifesciences Corp. - Vendor overview
Exhibit 71: Edwards Lifesciences Corp. - Product segments
Exhibit 72: Edwards Lifesciences Corp. - Organizational developments
Exhibit 73: Edwards Lifesciences Corp. - Geographic focus
Exhibit 74: Edwards Lifesciences Corp. - Segment focus
Exhibit 75: Edwards Lifesciences Corp. - Key offerings
Exhibit 76: NeoChord Inc. - Vendor overview
Exhibit 77: NeoChord Inc. - Business segments
Exhibit 78: NeoChord Inc. - Key offerings
Exhibit 79: Xeltis AG - Vendor overview
Exhibit 80: Xeltis AG - Business segments
Exhibit 81: Xeltis AG - Key offerings
Exhibit 82: Validation techniques employed for market sizing
Exhibit 83: Definition of market positioning of vendors

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

FEATURED COMPANIES

  • Abbott
  • BioVentrix Inc.
  • CryoLife Inc.
  • NeoChord Inc.
  • Xeltis AG
  • MORE
The analyst recognizes the following companies as the key players in the global cardiac restoration systems market: Abbott, BioVentrix Inc., CryoLife Inc., Edwards Lifesciences Corp., NeoChord Inc., and Xeltis AG.

Commenting on the report, an analyst from the team said: “The latest trend gaining momentum in the market is the development of mitral valve restoration systems with tissue engineering approach.”

According to the report, one of the major drivers for this market is the growing number of cardiovascular surgeries.

Further, the report states that one of the major factors hindering the growth of this market is the shortage of cardiologists.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 4
  • Abbott
  • BioVentrix Inc.
  • CryoLife Inc.
  • Edwards Lifesciences Corp.
  • NeoChord Inc.
  • Xeltis AG
Note: Product cover images may vary from those shown
Adroll
adroll